PCN96 Cost Minimization Analysis of Xeloda® Versus 5-Fluorouracil-Based Treatment for Gastric Cancer Patients in Hong Kong
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2136
https://www.valueinhealthjournal.com/article/S1098-3015(12)03850-8/fulltext
Title :
PCN96 Cost Minimization Analysis of Xeloda® Versus 5-Fluorouracil-Based Treatment for Gastric Cancer Patients in Hong Kong
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03850-8&doi=10.1016/j.jval.2012.08.2136
First page :
A426
Section Title :
Cancer
Open access? :
No
Section Order :
785